News | March 19, 2025
Croda opens advanced lipids manufacturing facility in Pennsylvania
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals
Increases speed to market for drug developers working on nucleic acid therapeutics
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Subscribe To Our Newsletter & Stay Updated
